Advisor Group Holdings, Inc. Exicure, Inc. Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.37 - $0.75 $52 - $107	-143 Reduced 33.1%	289 $0
Q3 2023 Nov 13, 2023	BUY	$0.71 - $1.36 $101 - $194	143 Added 49.48%	432 $0
Q2 2023 Aug 10, 2023	SELL	$0.85 - $1.44 $1,331 - $2,255	-1,566 Reduced 84.42%	289 $0
Q3 2022 Nov 14, 2022	BUY	$1.53 - $8.5 $2,142 - $11,900	1,400 Added 307.69%	1,855 $2,000
Q2 2022 Aug 10, 2022	BUY	$2.16 - $6.36 $982 - $2,893	455 New	455 $0

287K

Ticker XCUR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,962,580
Market Cap $85.3M
Description
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.